RhoA-induced suppression of the HSR decreases cell stress resistance and induces cell death via apoptosis. by Roelien A. M. Meijering (217816)

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

Decreased inflammatory markers of peritoneal macrophages following <i>in vivo</i> treatment with p30A peptide. by Jérôme Rambert (46851)

Copper ion concentration (A, Control; B, strain A; C, strain B; D, strain F) of MSM during fermentation for <i>S</i>. <i>cerevisiae</i> strains in MSM with 0 (control) (A*, B*, F*)... by Xiang-yu Sun (748032)

Mycolactone induces a decrease in dermal collagen fibers. by José B. Gama (296675)

A frame from the final video containing human-hearable audio track showing grooming behavior and FM USV call at frame #50. by Piotr Popik (292215)

ATG 5 down-regulation decreases human A53T ASYN-induced death in rat cortical neurons. by Maria Xilouri (264240)

EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

“…Arrows indicate lesion site. Scale bars in A–D, G,H, 100 µm; E,F, 50 µm.</p>…”

BKM120 decreases cellular glycolytic metabolic activity in MB cell lines. by Ping Zhao (47228)

Kinetic properties of [³H] WIN35,428 and [³H] Nisoxetine binding in PC12 cells expressing WT hNET and its mutants. by Matthew J. Strauss (13876538)

EQI decreases malonyl-CoA levels in <i>S</i>. <i>aureus</i>. by Erica C. Larson (1344687)

Dominant negative Rac1 and Rac1 siRNA both decrease H₂S-promoted cell migration and tube formation in HUVECs. by Li-Jia Zhang (308411)

Optic nerve head degeneration and decrease in RGCs observed in <i>Vav2^−/−Vav3^−/−</i> mice with elevated IOP. by Keiko Fujikawa (253775)

“…In those retinas, RGCs are decreased. Scale bars, from left to right side: 500 µm, 100 µm, and 50 µm. …”

Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

Subjects:

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Subjects:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Subjects:

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects: